Public Employees Retirement Association of Colorado’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,400
Closed -$21K 1929
2024
Q1
$21K Hold
1,400
﹤0.01% 1885
2023
Q4
$21K Hold
1,400
﹤0.01% 1895
2023
Q3
$20K Hold
1,400
﹤0.01% 1912
2023
Q2
$14K Hold
1,400
﹤0.01% 1934
2023
Q1
$13K Hold
1,400
﹤0.01% 1950
2022
Q4
$12K Hold
1,400
﹤0.01% 1949
2022
Q3
$12K Hold
1,400
﹤0.01% 1947
2022
Q2
$11K Hold
1,400
﹤0.01% 1955
2022
Q1
$12K Hold
1,400
﹤0.01% 1924
2021
Q4
$13K Hold
1,400
﹤0.01% 1937
2021
Q3
$24K Hold
1,400
﹤0.01% 1914
2021
Q2
$21K Hold
1,400
﹤0.01% 1915
2021
Q1
$27K Hold
1,400
﹤0.01% 1890
2020
Q4
$25K Hold
1,400
﹤0.01% 1889
2020
Q3
$27K Hold
1,400
﹤0.01% 1864
2020
Q2
$37K Buy
1,400
+300
+27% +$7.33K ﹤0.01% 1839
2020
Q1
$20K Hold
1,100
﹤0.01% 1782
2019
Q4
$37K Hold
1,100
﹤0.01% 1808
2019
Q3
$26K Hold
1,100
﹤0.01% 1842
2019
Q2
$40K Hold
1,100
﹤0.01% 1856
2019
Q1
$41K Buy
+1,100
New +$46.1K ﹤0.01% 1798

Other funds holding URGN

Public Employees Retirement Association of Colorado's URGN Position: Q2 2024 in Review

Public Employees Retirement Association of Colorado sold out of UroGen Pharma (URGN) in Q2 2024, closing a stake of 1,400 shares — an estimated $21K sold.

Public Employees Retirement Association of Colorado first reported a position in URGN in Q1 2019 and held it in 21 quarters. The position peaked at $41K in Q1 2019. 115 funds tracked by Wall St. Rank hold URGN as of Q2 2024.

  • Public Employees Retirement Association of Colorado reported no remaining UroGen Pharma position as of Q2 2024 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 1,400 UroGen Pharma shares in Q2 2024, an estimated $21K.
  • Public Employees Retirement Association of Colorado first reported a position in UroGen Pharma in Q1 2019 and held it in 21 quarters.
  • Public Employees Retirement Association of Colorado's UroGen Pharma position peaked at $41K in Q1 2019.
  • 115 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2024.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2024, filed 12 Aug 2024.